Acceptability and Tolerability of Extended Reality Relaxation Training with and without Wearable Neurofeedback in Pediatric Migraine.
Mark Connelly, Madeline Boorigie, Klanci McCabe
https://pubmed.ncbi.nlm.nih.gov/36832458Actively Recruiting
Led by Children's Mercy Hospital Kansas City · Updated on 2026-06-03
38
Participants Needed
1
Research Sites
N/A
Total Duration
C
Children's Mercy Hospital Kansas City
Lead Sponsor
N
National Center for Complementary and Integrative Health (NCCIH)
Collaborating Sponsor
Researchers are studying whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents aged 10 to 16 years with migraine. This trial aims to see if teenagers can be successfully enrolled, randomized, and retained while completing VR sessions and study procedures, and whether the program might improve migraine-related disability and symptoms. The study compares Immersive Neurofeedback Self-Regulation Training (INSeRT), which uses brain activity recorded from a wearable EEG headband, with a VR program that shows immersive imagery without neurofeedback or relaxation training. Participants complete a 4-week baseline period involving headache logs, questionnaires, and a lab EEG assessment. Then they are randomly assigned to either the INSeRT neurofeedback VR or the comparison VR imagery program. Both groups do VR sessions at home three times a week, each lasting about 8 minutes, over 4 weeks. Questionnaires and a repeat EEG assessment are done after treatment and again approximately 3 months later. During the study, participants log headaches, complete questionnaires, and undergo EEG brain activity tests to measure changes. Researchers track recruitment, randomization, treatment adherence, retention, and symptom changes. Outcomes include the number and duration of VR sessions completed, treatment credibility, cybersickness symptoms, and migraine disability scores. Participants are followed for about 3 months after treatment to assess longer-term effects and safety.
CONDITIONS
A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 4 weeks
Participants track headache patterns and undergo laboratory-based EEG assessment of cortical reactivity before starting treatment.
1 baseline visit (in-person) and home headache tracking
Duration - 4 weeks
Participants complete home-based virtual reality sessions either with neurofeedback or without neurofeedback, three times per week for about 8 minutes per session.
3 home-based sessions per week for 4 weeks
Duration - Up to approximately 3 months after treatment
Participants undergo laboratory-based EEG assessment post-treatment and complete surveys on treatment tolerability and usability. Clinical outcomes related to migraine are monitored for 3 months after treatment.
1 post-treatment EEG visit and periodic assessments during follow-up
Total: 1 location
1
Children's Mercy
Kansas City, Missouri, United States, 64108
Actively Recruiting
M
Mark A Connelly, PhD
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mark Connelly, Madeline Boorigie, Klanci McCabe
https://pubmed.ncbi.nlm.nih.gov/36832458